Sr. Medical Scientific Liaison
Pubblicato il 07-09-2026 - Acadia Pharmaceuticals in Italia
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference.
Sebbene l'esperienza qualificato e le qualifiche siano fondamentali per questo ruolo, si assicuri di verificare di possedere le soft skill preferenziali, se richieste, prima di candidarsi.
Position Summary: Senior Medical Science Liaison (Sr MSL) for Italy plays a pivotal role in advancing our mission in rare pediatric/adult neurodevelopmental diseases, with a core focus on Rett syndrome.
This field-based role serves as a trusted scientific partner to healthcare professionals, researchers, advocacy groups, and decision makers across Italy. The Sr MSL drives scientific exchange, supports evidence generation, and helps ensure patients, caregivers, and clinicians have access to high-quality scientific and medical information about Acadia’s therapeutic innovations.
Scope:Scientific Engagement & Stakeholder Partnership – Serve as Acadia’s field-based scientific expert, building trusted relationships with healthcare professionals, key opinion leaders, centers of excellence, and patient advocacy organizations across Italy, in close alignment with the country Medical Director and General Manager.
Medical Strategy & Insight Generation – Generate actionable field insights, identify unmet needs, and contribute to evidence generation, launch readiness, and lifecycle management initiatives in rare neurological diseases.